Publications
123
Citations
1,438
Est. group size
~2
Recurring co-author estimate
Active years
35
Publishing since 1991
Verónica Franco's clinical research focuses on pulmonary arterial hypertension (a disease causing high blood pressure in the lungs) and related heart failure conditions, including clinical trials of new inhaled and oral drug therapies (such as treprostinil, seralutinib, macitentan, and vardenafil) aimed at improving patients' exercise capacity and symptoms. The bibliographic record also includes a distinct set of publications on mentoring and educational equity for bilingual and underrepresented (BIPOC) students in graduate psychology and mental health training, suggesting involvement in academic mentoring initiatives alongside clinical research.
Publication output has grown over the last decade, rising from low single digits in 2017-2020 to a peak of 18 in 2023, followed by a slight decline in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A Single Dose of RT234, Vardenafil Inhaled via the Axial Oscillating Sphere Dry Powder Inhaler (AOS™ DPI), Acutely Improves Exercise Capacity and Reduces Dyspnea in Pulmonary Arterial Hypertension (PAH) Patients (WHO Group 1 PH) – Results From the Open-label Phase 2b CPET (Cardiopulmonary Exercise Testing) Study (NCT04266197)
American Journal of Respiratory and Critical Care Medicine · 2025
- Sueños y logros: Maximizing the college experience and applying to graduate school as aspiring bilingual mental health scientists-practitioners.
American Psychological Association eBooks · 2025
- Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
The Lancet Respiratory Medicine · 2024
- Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities
CHEST Journal · 2024
- SOPRANO: Macitentan in patients with pulmonary hypertension following left ventricular assist device implantation
Pulmonary Circulation · 2024
- CARDIOGENIC SHOCK DUE TO HANTAVIRUS CARDIOPULMONARY SYNDROME
Journal of the American College of Cardiology · 2024
- EFFICACY OF INTRAVENOUS IRON IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: AN UPDATED META-ANALYSIS
Journal of the American College of Cardiology · 2024
- Cardiac Effort Is Less Variable Than Six-minute Walk Distance, Correlates With Hemodynamics and Is Consistent With REVEAL 2.0 Risk Score in a Sub-study of the TORREY Phase 2 PAH Trial
2024
- Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil
Pulmonary Circulation · 2023
- Parenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil
Respiratory Medicine · 2023
- Mentoring
2023
- Riding the Academic Freedom Train
2023
- Seralutinib improves pulmonary arterial blood vessel volume distribution in pulmonary arterial hypertension (PAH): results of the TORREY phase 2 imaging substudy
2023
- Remodulin Induction Facilitates Rapid Achievement of Therapeutic Doses of Oral Treprostinil: Results From the EXPEDITE Study
2023
- Segregation in Education
2023
- The Journal of Heart and Lung Transplantation×10
- CHEST Journal×4
- Pulmonary Circulation×3
- Circulation×3
- Journal of the American College of Cardiology×3
- Raymond L. Benza
Medicine · The Ohio State University
- Rachel D’Amico
Medicine · The Ohio State University
- Shili Lin
Medicine · The Ohio State University
- Priscilla Correa‐Jaque
Medicine · The Ohio State University
- Rebecca Vanderpool
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile